These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23513480)

  • 41. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
    Suankratay C; Jutivorakool K; Jirajariyavej S
    J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extended-spectrum beta-lactamases and clinical outcomes: current data.
    Ramphal R; Ambrose PG
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S164-72. PubMed ID: 16544267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
    Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
    J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
    Lee CH; Su LH; Lin WC; Tang YF; Liu JW
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e183-6. PubMed ID: 19800278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of extended-spectrum-β-lactamase (ESBL) carrying Escherichia coli from sewage sludge and human urinary tract infection.
    Zarfel G; Galler H; Feierl G; Haas D; Kittinger C; Leitner E; Grisold AJ; Mascher F; Posch J; Pertschy B; Marth E; Reinthaler FF
    Environ Pollut; 2013 Feb; 173():192-9. PubMed ID: 23202650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
    Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
    Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for community- and health facility-acquired extended-spectrum β-lactamase-producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview.
    Siedelman L; Kline S; Duval S
    Am J Infect Control; 2012 Nov; 40(9):849-53. PubMed ID: 22325481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities.
    Tinelli M; Cataldo MA; Mantengoli E; Cadeddu C; Cunietti E; Luzzaro F; Rossolini GM; Tacconelli E
    J Antimicrob Chemother; 2012 Dec; 67(12):2982-7. PubMed ID: 22865381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
    Pinheiro HS; Mituiassu AM; Carminatti M; Braga AM; Bastos MG
    Transplant Proc; 2010 Mar; 42(2):486-7. PubMed ID: 20304172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge.
    Fakioglu E; Queenan AM; Bush K; Jenkins SG; Herold BC
    J Perinatol; 2006 Aug; 26(8):515-7. PubMed ID: 16871223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bacteraemia due to Escherichia coli producing extended-spectrum beta-lactamases (ESBL): clinical relevance and today's insights].
    García-Hernández AM; García-Vázquez E; Hernández-Torres A; Ruiz J; Yagüe G; Herrero JA; Gómez J
    Rev Esp Quimioter; 2011 Jun; 24(2):57-66. PubMed ID: 21666996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
    Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
    Winters HA; Parbhoo RK; Schafer JJ; Goff DA
    Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
    Araj GF; Jaber FA
    J Med Liban; 2012; 60(3):142-7. PubMed ID: 23198454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of extended spectrum beta lactamase in urinary isolates.
    Tankhiwale SS; Jalgaonkar SV; Ahamad S; Hassani U
    Indian J Med Res; 2004 Dec; 120(6):553-6. PubMed ID: 15654142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended-Spectrum β-Lactamase-Producing Escherichia coli in Neonates and Listeria monocytogenes in Young Children with Bacterial Meningitis in Japan.
    Furuichi M; Yaginuma M; Shinjoh M; Ohnishi T; Takahashi T; Iwata S
    J Pediatric Infect Dis Soc; 2023 Apr; 12(3):165-168. PubMed ID: 36525391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended-Spectrum Beta-Lactamase-Producing
    Puvabanditsin S; Jacob M; Jalil M; Bhattarai S; Patel Q; Sadiq M; Mehta R
    Case Rep Infect Dis; 2019; 2019():6874192. PubMed ID: 31032129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Escherichia coli extended spectrum beta-lactamase meningitis in 3 months infant with subdural abscess and communicating hydrocephalus: A case report.
    Miranda S; Harahap A; Mu'minin A; Putri AF; Pitaloka NI
    Int J Surg Case Rep; 2023 May; 106():108128. PubMed ID: 37054544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of acute nonspecific empyema].
    Safarov IS; Karabaev KhK; Abduzhalilov AA; Artamonov VI; Ishankulov AM
    Klin Khir (1962); 1990; (10):30-2. PubMed ID: 2280524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.